Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Codis is a pharmaceutical company primarily known for its range of analgesic products, most notably the Codis brand of soluble aspirin and codeine tablets. The company focuses on the development and distribution of over-the-counter (OTC) and prescription medications for pain management, inflammation, and fever. Its flagship products combine the anti-inflammatory properties of aspirin with the analgesic effects of codeine to provide relief for moderate to severe pain. Codis operates as a specialized entity within the broader healthcare market, often associated with major consumer health distributors. The company's portfolio is centered on established small molecule therapies with a long history of clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Codis.